> visit Canadian site

 

Live Help

View All Chapters

HOME
PATIENT SERVICES
Call Center
Información - Español
Newly Diagnosed
Find Support
Financial Support
First Connection Request
Stay Informed
Chapter Education Programs
Free Materials
Diseases
Treatments
Spanish Publications
French Publications
Fact Sheets
Support
Financial Health Matters Booklet
Publication Feedback
Discussion Boards
Question & Answers
Cancer Centers
DISEASE INFORMATION
HOW TO HELP
ADVOCACY
SCIENCE/PROFESSIONALS
LLS
Email:
Password:
Remember Me
Not Yet Registered?



This website is certified by Health On the Net Foundation. Click to verify.
 print page
email page
 $  Donate
Society News Feeds

Acute Myelogenous Leukemia (AML) (PS32)

Begin Reading...


 

Acute Myelogenous Leukemia (AML)

Introduction

Advances in the treatment of acute myelogenous leukemia (AML) have resulted in improved remission and cure rates.

About 13,410 new cases of AML will be diagnosed in the United States in 2007 (source: Surveillance, Epidemiology and End Results [SEER] Program; Cancer Statistics Review, 2000-2004; National Cancer Institute, 2007). Although AML can occur at any age, adults aged 65 years and older are more likely to develop the disease than younger people are. In 2004, AML accounted for almost 15 percent of childhood acute leukemia cases (source: Surveillance, Epidemiology, and End Results [SEER] Program; 1969-2004 Counties, National Cancer Institute, 2007).

This booklet provides information about AML for patients and their families. A brief description of normal blood and marrow is provided for background, followed by a detailed description of AML and its treatment. The booklet includes a glossary to help readers understand medical terms.

Continue reading by downloading the .pdf or order a free printed copy via the online order form.

If you need assistance ordering free materials please call the Information Resource Center at (800) 955-4572 or contact your local chapter.



last updated on 11/05/08

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Need Help? Contact us by email, mail, or call (800) 955-4572 copyright | disclaimer | link | privacy | security
spanish french portuguese